Clinical Trial Update: The Effect of Rituximab on the Humoral Response to Influenza Vaccine [NA]

View source ↗

Summary

A clinical trial evaluating how rituximab affects the humoral response to the influenza vaccine in rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Rheumatoid Arthritis | NA | Status: TERMINATED